Abiomed (NASDAQ: ABMD) is a global technology leader focused on RECOVERING HEARTS AND SAVING LIVES.

The Company's portfolio of heart support and recovery products and services offer healthcare professionals an array of choices across a broad clinical spectrum. From the catheterization lab to the surgical suite, together with interventional cardiologists and surgeons, Abiomed is dedicated to providing the most advanced medical technologies to heart patients, with the ultimate goal of heart recovery and improved quality of life.

Abiomed was founded more than two decades ago and is the only company in the world with exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The Company develops, manufactures and markets advanced medical technologies designed to assist or replace the pumping function of the failing heart. Abiomed is the global leader for products in the acute heart failure market and ships more ventricle assist devices (VADs) than any other company in the world.

The Company is focused on expanding its global distribution, fueling innovation and new products to broaden the Company's product portfolio to become the world's circulatory care leader.

Key Facts:

• Year Founded: 1981
• Corporate Headquarters: Danvers, Massachusetts
• European Division: Aachen, Germany
• Number of Employees: 300+

Product and Service Offerings:

• Heart Recovery and Assist: BVS 5000 Bi-ventricular Support System and AB5000 Circulatory Support System
• In Europe, Abiomed offers the IMPELLA® RECOVER® minimally invasive Cardiovascular Support Systems under CE mark approval
• Heart Replacement: the AbioCor Implantable Replacement Heart, and Under Development the AbioCor II